SCHEMBL6557871

SCHEMBL6557871

CC(C)CCCCN1CCC(=O)C1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 1/20 0.36
GRIA2 P42262 1/20 0.36
GRIA3 P42263 1/20 0.36
GRIA4 P48058 1/20 0.36
PIK3CD O00329 1/20 0.36
SORT1 Q99523 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTR1A P08908 2/20 0.35
DRD3 P35462 2/20 0.35
HTR7 P34969 1/20 0.35
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
ALDH1A1 P00352 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7384490 0.84 OPRM1 (0.39) GRIA1GRIA2GRIA3GRIA4PIK3CD
SCHEMBL7715035 0.79 ABCB1 (0.49) HTR1AALDH1A1THRBHPGDL3MBTL1
SCHEMBL6560074 0.78 L3MBTL1 (0.31) PIK3CDHTR1ADRD3HTR7ALDH1A1
SCHEMBL21047565 0.78 HTR1A (0.48) HTR1AALDH1A1THRBHPGDL3MBTL1
SCHEMBL21047883 0.78 HTR1A (0.48) HTR1AALDH1A1THRBHPGDL3MBTL1
SCHEMBL1732235 0.78 HTR1A (0.48) HTR1AALDH1A1THRBHPGDL3MBTL1
SCHEMBL21047618 0.78 HTR1A (0.48) HTR1AALDH1A1THRBHPGDL3MBTL1
SCHEMBL21047906 0.78 HTR1A (0.48) HTR1AALDH1A1THRBHPGDL3MBTL1
SCHEMBL8445221 0.77 ALDH1A1 (0.50) HTR1ADRD3ALDH1A1THRBHPGD
SCHEMBL13600646 0.76 PIK3CD (0.49) PIK3CDSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP disclosed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO disclosed